News + Filings Transactions Holdings
All 13F 13D/G Other
|
Foresite Capital Management II, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/11/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/12/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/13/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/13/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/12/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/24/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Disposed of 700,000 shares
@ $0 Acquired 178,584 shares
@ $0 Disposed of 178,584 shares
@ $0 Acquired 92,258 shares
@ $0 Converted 1,000,000 shares
@ $0 Converted 1,000,000 options to buy
@ $0 |
|
04/15/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Disposed of 788,317 shares
@ $0 Disposed of 433,725 shares
@ $0 Acquired 201,115 shares
@ $0 Disposed of 201,115 shares
@ $0 Acquired 21,686 shares
@ $0 Disposed of 21,686 shares
@ $0 Acquired 109,849 shares
@ $0 Converted 1,500,000 shares
@ $0 Converted 1,500,000 options to buy
@ $0 |
|
03/26/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Converted 2,170,619 shares
@ $0 Converted 2,170,619 options to buy
@ $0 |
|
03/19/2020 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Converted 1,447,079 shares
@ $0 Converted 683,725 shares
@ $0 Sold 500,000 shares
@ $59, valued at
$29.5M
Sold 250,000 shares
@ $59, valued at
$14.8M
Disposed of 947,079 shares
@ $0 Acquired 241,619 shares
@ $0 Disposed of 241,619 shares
@ $0 Acquired 125,276 shares
@ $0 Converted 1,447,079 options to buy
@ $0 Converted 683,725 options to buy
@ $0 |
|
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/05/2019 |
3/A
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 3/A on AERIE PHARMACEUTICALS INC |
09/16/2019 |
4
| Foresite Capital Management I, LLC (10% Owner) has filed a Form 4 on 10x Genomics, Inc.
Txns:
| Bought 187,500 shares
@ $39, valued at
$7.3M
Converted 5,487,470 convertible preferred
@ $0 Converted 1,002,166 convertible preferred
@ $0 Converted 558,260 convertible preferred
@ $0 Converted 5,513,058 convertible preferred
@ $0 Converted 1,324,195 convertible preferred
@ $0 Converted 7,047,896 options to buy
@ $0 Converted 6,837,253 options to buy
@ $0 |
|
09/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/06/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Bought 9,300 shares
@ $18.48, valued at
$171.9k
Bought 90,900 shares
@ $18.48, valued at
$1.7M
Bought 15,700 shares
@ $18.42, valued at
$289.2k
|
|
09/04/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Bought 25,000 shares
@ $21.36, valued at
$534k
Bought 34,900 shares
@ $20.54, valued at
$716.8k
Bought 15,100 shares
@ $21.45, valued at
$323.9k
|
|
08/23/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Bought 1,153 shares
@ $23.25, valued at
$26.8k
Bought 6,700 shares
@ $23.68, valued at
$158.7k
Bought 38,300 shares
@ $23.42, valued at
$897k
|
|
08/20/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Bought 100,000 shares
@ $24.23, valued at
$2.4M
Bought 3,847 shares
@ $23.34, valued at
$89.8k
Bought 50,000 shares
@ $23.21, valued at
$1.2M
|
|
08/14/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns:
| Bought 189,555 shares
@ $24.43, valued at
$4.6M
Bought 71,097 shares
@ $24.92, valued at
$1.8M
Bought 178,903 shares
@ $25.52, valued at
$4.6M
Bought 100,000 shares
@ $23.73, valued at
$2.4M
|
|
08/14/2019 |
3
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 3 on AERIE PHARMACEUTICALS INC |
08/13/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/14/2019 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|